{"mainPropery":{"diseaseId":6529,"diseaseName":"Glycogen storage disease type 6","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/6529/glycogen-storage-disease-type-6","synonyms":["GSD6","Glycogen storage disease 6","Hers disease","Phosphorylase deficiency glycogen-storage disease of liver"],"synonyms-with-source":[{"name":"GSD6"},{"name":"Glycogen storage disease 6"},{"name":"Hers disease"},{"name":"Phosphorylase deficiency glycogen-storage disease of liver"}],"identifiers":[{"identifierType":"OMIM","identifierId":"232700"},{"identifierType":"ORPHANET","identifierId":"369"},{"identifierType":"UMLS","identifierId":"C0017925"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":6,"diseaseTypeName":"Digestive Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"}],"organizations":[{"resourceID":138,"resourceName":"Metabolic Support UK","abbreviation":"","address1":"5 Hilliards Court","address2":"Sandpiper Way","address3":"Chester Business Park","address4":"","address5":"","city":"Chester","state":"","zip":"CH4 9QP","country":"United Kingdom","phone":"0845 241 2173","tty":"","tollFree":"0800 652 3181 ","fax":"","email":"https://www.metabolicsupportuk.org/contact-us","url":"https://www.metabolicsupportuk.org","freeText":""},{"resourceID":302,"resourceName":"Association for Glycogen Storage Disease UK","abbreviation":"AGSD-UK","address1":"PO Box 1232","address2":"Bristol","address3":"BS48 9DD","address4":"","address5":"","city":"","state":"","zip":"","country":"United Kingdom","phone":"0300 123 2790","tty":"","tollFree":"","fax":"","email":"https://agsd.org.uk/contact/message-us2/","url":"http://www.agsd.org.uk/","freeText":""},{"resourceID":3749,"resourceName":"Canadian Association for Glycogen Storage Disease","abbreviation":"","address1":"P.O Box 56009","address2":"Vancouver","address3":"British Columbia","address4":"","address5":"","city":"","state":"","zip":"V5L5E2","country":"Canada","phone":"","tty":"","tollFree":"","fax":"","email":"","url":"https://www.facebook.com/canadianagsd/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/232700' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?itool=omim_Detailed&DbFrom=omim&Cmd=Link&LinkName=omim_pubmed_calculated&IdsFromResult=232700' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Glycogen storage disease type 6. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/401/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/119873-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=369' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:232700' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":6579,"questionText":"What is glycogen storage disease type 6?","answerText":"<strong>Glycogen storage disease type 6 (GSD6)&nbsp;<strong></strong></strong>is a genetic disease in which the&nbsp;<a href=\"https://medlineplus.gov/ency/imagepages/8848.htm\">liver</a>&nbsp;cannot process sugar properly.[5668] The liver is responsible for breaking down a substance called&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/books/NBK21190/\">glycogen</a>. Glycogen is the stored form of sugar that is made by breaking down&nbsp;<a href=\"https://medlineplus.gov/carbohydrates.html\">carbohydrates</a>.[13927] When the liver cannot break down glycogen properly it causes a buildup that is damaging to the body. Symptoms of the disease usually begin in infancy or childhood and include low blood sugar (<a href=\"https://medlineplus.gov/hypoglycemia.html\">hypoglycemia</a>), an enlarged liver (<a href=\"https://medlineplus.gov/ency/article/003275.htm\">hepatomegaly</a>), and an increase in the amount of lactic acid in the blood (<a href=\"https://medlineplus.gov/ency/article/000391.htm\">lactic acidosis</a>). These symptoms are especially likely to occur when an individual does not eat for a long time. Symptoms tend to improve as people with this disease get older. The disease is especially common in the Mennonite population.[5668]<br />\r\n<br />\r\nGSD6 is caused by&nbsp;<a href=\"https://ghr.nlm.nih.gov/primer/mutationsanddisorders/genemutation\">mutations</a>&nbsp;(changes) in the&nbsp;<a href=\"https://ghr.nlm.nih.gov/gene/PYGL\"><em>PYGL</em></a><em>&nbsp;</em><a href=\"https://ghr.nlm.nih.gov/primer/basics/gene\">gene</a>. The disease is inherited in an&nbsp;<a href=\"https://medlineplus.gov/ency/article/002052.htm\">autosomal recessive</a>&nbsp;manner.[5668] The diagnosis is made based on&nbsp;<a href=\"https://ghr.nlm.nih.gov/primer/testing/genetictesting\">genetic testing</a>&nbsp;of the&nbsp;<em>PYGL</em>&nbsp;gene. A&nbsp;<a href=\"https://medlineplus.gov/ency/article/003895.htm\">liver biopsy</a>&nbsp;that tests the function of liver glycogen phosphorylase may be necessary if the results of the genetic testing are inconclusive. Treatment may include eating frequent meals that are high in carbohydrates.[13927]","dateModified":"2017-10-12T00:00:00"},"basicQuestions":[{"questionId":12286,"questionText":"What are the symptoms of glycogen storage disease type 6?","answerText":"Symptoms of GSD6 usually begin in infancy or childhood and may include an enlarged liver (<a href=\"https://medlineplus.gov/ency/article/003275.htm\">hepatomegaly</a>).&nbsp; Other symptoms of the disease include low blood sugar (<a href=\"https://medlineplus.gov/hypoglycemia.html\">hypoglycemia</a>) or an increase in the amount of lactic acid in the blood (<a href=\"https://medlineplus.gov/ency/article/000391.htm\">lactic acidosis</a>). Hypoglycemia can also cause symptoms such as faintness, weakness, hunger, and nervousness.[13927] The symptoms of the disease are especially likely to occur when an individual does not eat for a long time.[5668] In some cases, children with glycogen storage disease type 6 have slow growth (growth retardation) or muscle weakness (<a href=\"https://medlineplus.gov/ency/article/003298.htm\">hypotonia</a>).[13927]<br />\r\n<br />\r\nPeople with GSD6 may be at an increased risk to have liver cancer or an enlarged heart (<a href=\"https://medlineplus.gov/cardiomyopathy.html\">cardiomyopathy</a>).[13928][13929] Many of the symptoms of GSD6 tend to improve as the child gets older. Adults with the disease frequently do not have hepatomegaly, and they are not expected to be shorter than other individuals.[13927]","dateModified":"2017-10-12T17:38:00","resourceClassificationName":"Symptoms","references":[{"referenceId":5668,"authors":"","articleTitle":"Glycogen storage disease type VI","bookWebsiteJournalTitle":"Genetics Home Reference","date":"September 2010","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/glycogen-storage-disease-type-vi","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13927,"authors":"","articleTitle":"Hers Disease","bookWebsiteJournalTitle":"National Organization for Rare Disorders","date":"2007","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/hers-disease/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13928,"authors":"Roscher A, Patel J, Hewson S, Nagy L, Feigenbaum A, Kronick J, Raiman J, Schulze A, Siriwardena K, and Mercimek-Mahmutoglu S","articleTitle":"The natural history of glycogen storage diseases type VI and IX: Long-term outcome from the largest metabolic center in Canada","bookWebsiteJournalTitle":"Molecular Genetics and Metabolism","date":"November 2014","volume":"113(3)","pages":"171-176","url":"https://www.ncbi.nlm.nih.gov/pubmed/25266922","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13929,"authors":"Dagli AI and Weinstein DA","articleTitle":"Glycogen Storage Disease Type VI","bookWebsiteJournalTitle":"GeneReviews","date":"May 17, 2011","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK5941/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12287,"questionText":"What causes glycogen storage disease type 6?","answerText":"GSD6 is caused by changes or&nbsp;<a href=\"https://ghr.nlm.nih.gov/primer/mutationsanddisorders/genemutation\">mutations</a>&nbsp;in the&nbsp;<a href=\"https://ghr.nlm.nih.gov/gene/PYGL\"><em>PYGL</em></a>&nbsp;<a href=\"https://ghr.nlm.nih.gov/primer/basics/gene\">gene</a>. This gene is responsible for telling the body how to make an&nbsp;<a href=\"https://medlineplus.gov/ency/article/002353.htm\">enzyme</a>&nbsp;called liver glycogen phosphorylase. This enzyme is partly responsible for breaking down glycogen. Glycogen is a form of energy that comes from carbohydrates and is stored in the liver. When the body needs more energy, glycogen in the liver is broken down by glycogen phosphorylase.[5668]&nbsp;<br />\r\n<br />\r\nWhen there are mutations in the&nbsp;<em>PYGL&nbsp;</em>gene, there is not enough functioning glycogen phosphorylase to break down glycogen. Therefore, glycogen starts to build up in the liver cells, which causes&nbsp;<a href=\"https://medlineplus.gov/ency/article/003275.htm\">hepatomegaly</a>. This also means that the body does not get enough energy, which causes symptoms such as hypoglycemia and lactic acidosis.[5668]","dateModified":"2017-10-12T17:44:00","resourceClassificationName":"Cause","references":[{"referenceId":5668,"authors":"","articleTitle":"Glycogen storage disease type VI","bookWebsiteJournalTitle":"Genetics Home Reference","date":"September 2010","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/glycogen-storage-disease-type-vi","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12288,"questionText":"How is glycogen storage disease type 6 inherited?","answerText":"GSD6 is inherited in an&nbsp;<a href=\"https://medlineplus.gov/ency/article/002052.htm\">autosomal recessive</a>&nbsp;manner.[5668] This means that both copies of the&nbsp;<a href=\"https://ghr.nlm.nih.gov/gene/PYGL\"><em>PYGL</em></a><em>&nbsp;</em><a href=\"https://ghr.nlm.nih.gov/primer/basics/gene\">gene</a>&nbsp;must be changed in order to have symptoms of the disease. We inherit one copy of each gene from our mother and the other from our father.&nbsp;<br />\r\n<br />\r\nPeople with a mutation in only one copy of the&nbsp;<em>PYGL</em>&nbsp;gene are known as carriers. Most carriers do not have any symptoms of the disease. When two carriers of glycogen storage disease type 6 have children together, for each child there is a:<br />\r\n<ul>\r\n    <li>25% chance that the child will have glycogen storage disease type 6</li>\r\n    <li>50% chance that the child will be a carrier of glycogen storage disease type 6 like the parents</li>\r\n    <li>25% chance that the child will have two working copies of&nbsp;<em>PYGL</em>, so the child will not have glycogen storage disease type 6 and will not be a carrier.</li>\r\n</ul>","dateModified":"2017-10-12T17:45:00","resourceClassificationName":"Inheritance","references":[{"referenceId":5668,"authors":"","articleTitle":"Glycogen storage disease type VI","bookWebsiteJournalTitle":"Genetics Home Reference","date":"September 2010","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/glycogen-storage-disease-type-vi","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12289,"questionText":"How is glycogen storage disease type 6 diagnosed?","answerText":"GSD6 is diagnosed when a healthcare provider observes signs and symptoms of the disease such as an&nbsp;<a href=\"https://medlineplus.gov/ency/article/003275.htm\">enlarged liver</a>&nbsp;and&nbsp;<a href=\"https://medlineplus.gov/hypoglycemia.html\">hypoglycemia</a>.[13930] The diagnosis is made based on&nbsp;<a href=\"https://ghr.nlm.nih.gov/primer/testing/genetictesting\">genetic testing</a>&nbsp;of the&nbsp;<a href=\"https://ghr.nlm.nih.gov/gene/PYGL\"><em>PYGL</em></a><em>&nbsp;</em><a href=\"https://ghr.nlm.nih.gov/primer/basics/gene\">gene</a>. A&nbsp;<a href=\"https://medlineplus.gov/ency/article/003895.htm\">liver biopsy</a>&nbsp;that tests the function of liver glycogen phosphorylase may be necessary if the results of the genetic testing are not clear.[13929]&nbsp;","dateModified":"2017-10-12T17:46:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":13929,"authors":"Dagli AI and Weinstein DA","articleTitle":"Glycogen Storage Disease Type VI","bookWebsiteJournalTitle":"GeneReviews","date":"May 17, 2011","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK5941/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13930,"authors":"Anderson WE","articleTitle":"Type VI Glycogen Storage Disease","bookWebsiteJournalTitle":"Medscape Reference","date":"December 5, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/119873-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12290,"questionText":"How might glycogen storage disease type 6 be treated?","answerText":"The primary treatment for GSD6 is to avoid prolonged periods of time without eating. Because glycogen is only broken down when stored energy is needed, eating frequent meals can avoid the need to break down glycogen. Levels of blood glucose should be monitored to make sure that the diet is working properly.[13927][13929] This will minimize the symptoms of the disease. In some cases, no other treatment is necessary. Uncooked cornstarch may be helpful for some people with GSD6. Uncooked cornstarch is a complex carbohydrate that is difficult for the body to digest; therefore it maintains normal blood sugar levels for a longer period of time than most carbohydrates in food.[13927][13928][13929][13931] For children who have muscle weakness, a high-protein diet may also be recommended.[13928][13930]","dateModified":"2017-10-12T17:49:00","resourceClassificationName":"Treatment","references":[{"referenceId":13927,"authors":"","articleTitle":"Hers Disease","bookWebsiteJournalTitle":"National Organization for Rare Disorders","date":"2007","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/hers-disease/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13928,"authors":"Roscher A, Patel J, Hewson S, Nagy L, Feigenbaum A, Kronick J, Raiman J, Schulze A, Siriwardena K, and Mercimek-Mahmutoglu S","articleTitle":"The natural history of glycogen storage diseases type VI and IX: Long-term outcome from the largest metabolic center in Canada","bookWebsiteJournalTitle":"Molecular Genetics and Metabolism","date":"November 2014","volume":"113(3)","pages":"171-176","url":"https://www.ncbi.nlm.nih.gov/pubmed/25266922","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13929,"authors":"Dagli AI and Weinstein DA","articleTitle":"Glycogen Storage Disease Type VI","bookWebsiteJournalTitle":"GeneReviews","date":"May 17, 2011","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK5941/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13930,"authors":"Anderson WE","articleTitle":"Type VI Glycogen Storage Disease","bookWebsiteJournalTitle":"Medscape Reference","date":"December 5, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/119873-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13931,"authors":"","articleTitle":"Type VI Glycogen Storage Disease","bookWebsiteJournalTitle":"Association for Glycogen Storage Disease","date":"","volume":"","pages":"","url":"http://www.agsdus.org/type-vi.php","dateAccessed":"2017-10-04T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12291,"questionText":"What is the long-term outlook for people affected by glycogen storage disease type 6?","answerText":"The signs and symptoms of GSD6 tend to improve with age. In general, it is thought that the body can adapt to low blood sugar levels and produce energy through alternate methods.[13927] Therefore, the long-term outlook for people affected by the disease is often good. However, if the symptoms of the disease are not well controlled with diet, additional symptoms such as delayed puberty and&nbsp;<a href=\"https://medlineplus.gov/osteoporosis.html\">osteoporosis</a>&nbsp;may develop.[13929]&nbsp;<br />\r\n<br />\r\nAdults are typically of a normal height and do not have muscle weakness. Liver problems associated with the disease tend to resolve as people get older, and the need for treatment for liver problems is rare in adulthood.[13930]","dateModified":"2017-10-12T17:53:00","resourceClassificationName":"Prognosis","references":[{"referenceId":13927,"authors":"","articleTitle":"Hers Disease","bookWebsiteJournalTitle":"National Organization for Rare Disorders","date":"2007","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/hers-disease/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13929,"authors":"Dagli AI and Weinstein DA","articleTitle":"Glycogen Storage Disease Type VI","bookWebsiteJournalTitle":"GeneReviews","date":"May 17, 2011","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK5941/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13930,"authors":"Anderson WE","articleTitle":"Type VI Glycogen Storage Disease","bookWebsiteJournalTitle":"Medscape Reference","date":"December 5, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/119873-overview","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":12259,"relatedDiseaseName":"Glycogen storage disease","relation":"Parent","isRare":false,"hasGardPage":false}],"gardCases":[{"caseId":37310,"abbreviatedInquiry":"When a person has an autosomal recessive condition like glycogen storage disease type VI, what is the likelihood that their child will have the disorder?","caseQuestions":[{"questionId":6578,"questionText":"What is the chance that&nbsp;a child of an individual with glycogen storage disease type 6 will also have this condition?","answerText":"The chance that a child of an individual who has glycogen storage disease type 6 will also have this condition depends on whether the unaffected parent is a <a href=\"http://www.genome.gov/glossary/?id=23\" target=_blank>carrier</a> of this disease.<br>\r\n<ul>\r\n<li>If the unaffected parent is not a carrier, each child will not be affected but will be a carrier for this condition. \r\n<li>If the unaffected parent is a carrier, each child has a 50% chance of being affected by the condition and a 50% chance of being an unaffected&nbsp;carrier.</li></ul>\r\n<p>Genetic testing may help to determine if the unaffected parent is a carrier, and speaking with a genetics professional may help a couple to better understand the chance of future offspring inheriting this condition.</p>","dateModified":"2012-12-04T22:14:00","references":[]},{"questionId":2567,"questionText":"How can I find a genetics professional in my area?","answerText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by  the <a href=\"https://www.acmg.net/ACMG/Find_Genetic_Services/ACMG/ISGweb/FindaGeneticService.aspx?hkey=720856ab-a827-42fb-a788-b618b15079f9\" target=\"_blank\">American College of Medical Genetics</a>&nbsp;and the&nbsp;<a href=\"https://www.findageneticcounselor.com/\" target=\"_blank\">National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also <a href=\"http://ghr.nlm.nih.gov/handbook/consult?show=all\" target=\"_blank\">learn more about genetic consultations</a> from Genetics Home Reference.","dateModified":"2017-12-06T00:00:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10173,"phenoTypeName":"Increased hepatic glycogen content","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6028,"phenoTypeName":"Delayed puberty","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4319,"phenoTypeName":"Elevated hepatic transaminase","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4081,"phenoTypeName":"Failure to thrive","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13041,"phenoTypeName":"Hypoglycemia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13048,"phenoTypeName":"Ketosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10265,"phenoTypeName":"Osteopenia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10268,"phenoTypeName":"Osteoporosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10959,"phenoTypeName":"Abdominal distention","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5287,"phenoTypeName":"Exercise-induced muscle cramps","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5690,"phenoTypeName":"Hepatic fibrosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14535,"phenoTypeName":"Hyperlipidemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10797,"phenoTypeName":"Intermittent lactic acidemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10038,"phenoTypeName":"Irritability","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8729,"phenoTypeName":"Motor delay","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8716,"phenoTypeName":"Muscular hypotonia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10211,"phenoTypeName":"Portal fibrosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3779,"phenoTypeName":"Postexertional malaise","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3605,"phenoTypeName":"Short stature","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11439,"phenoTypeName":"Sleep disturbance","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10011,"phenoTypeName":"Abnormality of the kidney","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":5689,"phenoTypeName":"Cirrhosis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":5694,"phenoTypeName":"Hepatocellular carcinoma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8970,"phenoTypeName":"Hypertrophic cardiomyopathy","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13266,"phenoTypeName":"Postprandial hyperlactemia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":10031,"phenoTypeName":"Proteinuria","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":4090,"phenoTypeName":"Failure to thrive in infancy","percentRanges":"-"},{"phenoTypeId":14568,"phenoTypeName":"Hypercholesterolemia","percentRanges":"-"},{"phenoTypeId":13752,"phenoTypeName":"Hypertriglyceridemia","percentRanges":"-"},{"phenoTypeId":3414,"phenoTypeName":"Postnatal growth retardation","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Glycogen_storage_disease_type_6"}